KemPharm, Inc. (KMPHD): Price and Financial Metrics
KMPHD Price/Volume Stats
| Current price | $8.25 | 52-week high | $22.08 |
| Prev. close | $9.31 | 52-week low | $1.94 |
| Day low | $8.15 | Volume | 139,300 |
| Day high | $10.10 | Avg. volume | 58,750 |
| 50-day MA | $12.77 | Dividend yield | N/A |
| 200-day MA | $8.11 | Market Cap | 35.60M |
KMPHD Stock Price Chart Interactive Chart >
KemPharm, Inc. (KMPHD) Company Bio
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs in the United States. Its product candidate includes KP415 and KP484 for the treatment of attention deficit hyperactivity disorder; and KP879 for the treatment of stimulant use disorder. The company also provides APADAZ, an immediate-release combination product candidate of benzhydrocodone and acetaminophen to treat the short-term management of acute pain. It has a collaboration agreement with KVK-Tech, Inc. to manufacture and commercialize APADAZ. The company was founded in 2006 and is headquartered in Celebration, Florida.
KMPHD Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 84.55% |
| 2019 | N/A |
Loading social stream, please wait...